Abstract
(E)- and (Z)-3-Ferrocenylmethylidene-1,3-dihydro-2H-indol-2-ones 1 have been structurally modified in order to explore SAR against a range of kinases. Of note is the submicromolar to low micromolar inhibition of DYRK3 and 4 by a number of complexes. Screening using Xenopus embryos showed some of the compounds to have potent antiangiogenisis activity.
| Original language | English |
|---|---|
| Pages (from-to) | 600-608 |
| Journal | Metallomics |
| Volume | 3 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2011 |